Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy.

Great attention has been paid to the impressive role the macromolecules played in cancer immunotherapy, however, the applications were largely limited by their poor circulation stability, low cellular uptake efficiency, and off-target effects. As an important messenger of intercellular communication, extracellular vesicles (EVs) exhibit unique advantages in macromolecule delivery compared to traditional synthetic carriers, offering new possibilities for modern drug delivery. These naturally derived carriers can achieve stable, efficient, and selective delivery of macromolecules and improve the efficacy and potentiality of macromolecular drugs in cancer immunotherapy. This review provides a brief overview of the unique features of EVs related to macromolecule delivery, the strategies and recent advances of using EVs as macromolecule delivery carriers in cancer immunotherapy. [Display omitted] • Advances in applying extracellular vesicles (EVs) for macromolecule delivery. • Uptake mechanism, pharmacokinetic characteristics, and biodistribution of EVs. • Perspectives of EV-based macromolecule delivery for cancer immunotherapy [ABSTRACT FROM AUTHOR]